Synergy™ Neo2 Multi-Mode Microplate Reader is designed for speed and ultra high performance, incorporating BioTek’s patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics and up to 4 PMTs provide ultra-fast measurements with excellent results. Advanced environment controls, including available CO2/O2 control, incubation to 65 °C and variable shaking support live cell assays; cell-based detection is optimized with direct bottom illumination. Barcode-labeled filter cubes help streamline workflows and limit errors, while the available BioStackNeo plate stacker is the fastest on the market - ideal for high throughput requirements. Powerful Gen5™ Data Analysis Software is included, and features designed for 21 CFR Part 11 compliance are available in Gen5 Secure.
The available BioStack Neo integrates with Synergy Neo2 for fast automated processing of up to 50 plates.
BioTek Instruments, Inc. is a global leader in the development, manufacture and sale of microplate instrumentation and software. The company's origins date back to 1968, when Dr. Norman Alpert, a physiologist at the University of Vermont Medical College, founded BioTek. Dedicated to providing test equipment solutions for the hospital safety and quality assurance markets, BioTek's Biomedical Division grew to become one of the largest and most successful companies in the field. Looking to expand into a growing Life Science market and capitalize on the increasing popularity of non-isotopic immunoassays, BioTek entered the microplate instrument arena, and in 1981 introduced its first microplate reader. Since then, BioTek has emerged as a global leader in bioanalytical, and laboratory systems. With the sale of our Biomedical Division in 2002, BioTek today is completely focused on microplate instrumentation, automation and software, and continues to be a privately held, family-run organization.